Skip to main content
If you continue browsing this website, you agree to our policies:
Cookie Statement
Privacy Policy
Personal Data Protection Policy
Continue
x
Welcome to the Wits RHI eLearning Portal.
Font size:
A
A
A
×
Forgot your username or password?
Search
Close
Log in
Close
Gilead MOP: A Phase 2, Open-label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Long-Acting Lenacapavir in Combination With an Optimized Background Regimen in Treatment-experienced Adolescents and Chi
Home
Courses
Shandukani Research Centre
Protocols and MOPs
Shan_Gilead_MOP_V1
Summary
Gilead MOP: A Phase 2, Open-label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Long-Acting Lenacapavir in Combination With an Optimized Background Regimen in Treatment-experienced Adolescents and Chi
Enter this course
Should you have any navigation queries, please email wrhitraining@academicadvance.co.za.
Hide sidebars
